KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $274.6 million.

  • Idexx Laboratories' Income from Continuing Operations rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Income from Continuing Operations is $274.6 million, which was down 6.59% from $294.0 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Income from Continuing Operations registered a high of $294.0 million during Q2 2025, and its lowest value of $132.0 million during Q2 2022.
  • Its 3-year average for Income from Continuing Operations is $231.3 million, with a median of $224.2 million in 2023.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first surged by 82.64% in 2021, then tumbled by 34.86% in 2022.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Income from Continuing Operations stood at $162.8 million in 2021, then grew by 5.80% to $172.2 million in 2022, then increased by 12.96% to $194.5 million in 2023, then rose by 11.12% to $216.1 million in 2024, then grew by 17.94% to $274.6 million in 2025.
  • Its Income from Continuing Operations was $274.6 million in Q3 2025, compared to $294.0 million in Q2 2025 and $242.7 million in Q1 2025.